{"filing":{"accession_number":"0001654954-26-005989","cik":"0001304161","ticker":"PBSV","company_name":"Pharma-Bio Serv, Inc.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"pbsv_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1304161/000165495426005989/pbsv_8k.htm"},"events":[{"id":11137,"run_id":9760,"accession_number":"0001654954-26-005989","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a press release announcing quarterly financial results for the period ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's financial condition and operating results.","company_name":"Pharma-Bio Serv, Inc.","ticker":"PBSV","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7649,"accession_number":"0001654954-26-005989","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing quarterly financial results for the period ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's financial condition and operating results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:07:08.069933+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7649,"accession_number":"0001654954-26-005989","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing quarterly financial results for the period ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's financial condition and operating results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:07:08.069933+00:00","company_name":"Pharma-Bio Serv, Inc.","ticker":"PBSV","filing_date":"2026-06-15"}]}